Volinanserin is a selective serotonin receptor antagonist belonging to the piperidinemethanol class, primarily developed for the treatment of obsessive-compulsive disorder and related anxiety disorders.… Read more
Volinanserin is a selective serotonin receptor antagonist belonging to the piperidinemethanol class, primarily developed for the treatment of obsessive-compulsive disorder and related anxiety disorders. By blocking specific serotonin receptors to modulate neural pathways, this compound helps address compulsive behaviors. In analytical chemistry and pharmaceutical development, high-quality reference standards are essential for characterizing this active pharmaceutical ingredient. Laboratories utilize Volinanserin impurity standards and stable isotope labelled compounds, such as deuterated analogs like Volinanserin-d4 and Volinanserin-d6, for precise impurity profiling and method validation. These labelled compounds serve as critical internal standards in mass spectrometry and quality control assays, enabling accurate quantification of drug substances in complex matrices. By incorporating these analytical tools, researchers can ensure rigorous compliance with regulatory testing requirements throughout the drug development lifecycle.